These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 29133274)

  • 1. Gender differences in the impact of anemia on subclinical myocardial damage and cardiovascular mortality in the general population: The Yamagata (Takahata) study.
    Honda Y; Watanabe T; Otaki Y; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Shibata Y; Konta T; Kawasaki R; Daimon M; Ueno Y; Kato T; Kayama T; Kubota I
    Int J Cardiol; 2018 Feb; 252():207-212. PubMed ID: 29133274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study.
    Otaki Y; Watanabe T; Takahashi H; Hirayama A; Narumi T; Kadowaki S; Honda Y; Arimoto T; Shishido T; Miyamoto T; Konta T; Shibata Y; Fukao A; Daimon M; Ueno Y; Kato T; Kayama T; Kubota I
    PLoS One; 2014; 9(5):e94834. PubMed ID: 24847804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of restrictive lung disorder on cardiovascular mortality in a general population: The Yamagata (Takahata) study.
    Honda Y; Watanabe T; Shibata Y; Otaki Y; Kadowaki S; Narumi T; Takahashi T; Kinoshita D; Yokoyama M; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Inoue S; Miyamoto T; Konta T; Kawasaki R; Daimon M; Kato T; Ueno Y; Kayama T; Kubota I
    Int J Cardiol; 2017 Aug; 241():395-400. PubMed ID: 28442234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum uric acid levels and mortality in the Japanese population: the Yamagata (Takahata) study.
    Kamei K; Konta T; Ichikawa K; Sato H; Suzuki N; Kabasawa A; Suzuki K; Hirayama A; Shibata Y; Watanabe T; Kato T; Ueno Y; Kayama T; Kubota I
    Clin Exp Nephrol; 2016 Dec; 20(6):904-909. PubMed ID: 26779905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of Myocardial Damage Predicts Future Development of Hypertension in a Normotensive Japanese General Population: The Yamagata (Takahata) Study.
    Honda Y; Watanabe T; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Shibata Y; Konta T; Kayama T; Kubota I
    Am J Hypertens; 2018 Apr; 31(5):549-556. PubMed ID: 29342240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Hemoglobin Concentration and Its Change With Cardiovascular and All-Cause Mortality.
    Lee G; Choi S; Kim K; Yun JM; Son JS; Jeong SM; Kim SM; Park SM
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29378732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia in the general population: prevalence, clinical correlates and prognostic impact.
    Martinsson A; Andersson C; Andell P; Koul S; Engström G; Smith JG
    Eur J Epidemiol; 2014 Jul; 29(7):489-98. PubMed ID: 24952166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Superoxide Dismutase-1 Genetic Variation on Cardiovascular and All-Cause Mortality in a Prospective Cohort Study: The Yamagata (Takahata) Study.
    Otaki Y; Watanabe T; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Konta T; Shibata Y; Sato H; Kawasaki R; Daimon M; Ueno Y; Kato T; Kayama T; Kubota I
    PLoS One; 2016; 11(10):e0164732. PubMed ID: 27755600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the Aspartate Aminotransferase to Alanine Aminotransferase Ratio with BNP Level and Cardiovascular Mortality in the General Population: The Yamagata Study 10-Year Follow-Up.
    Yokoyama M; Watanabe T; Otaki Y; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Konta T; Shibata Y; Daimon M; Ueno Y; Kato T; Kayama T; Kubota I
    Dis Markers; 2016; 2016():4857917. PubMed ID: 27872510
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study.
    von Eynatten M; Breitling LP; Roos M; Baumann M; Rothenbacher D; Brenner H
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2327-35. PubMed ID: 22679309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Frequency of Laughter With Risk of All-Cause Mortality and Cardiovascular Disease Incidence in a General Population: Findings From the Yamagata Study.
    Sakurada K; Konta T; Watanabe M; Ishizawa K; Ueno Y; Yamashita H; Kayama T
    J Epidemiol; 2020 Apr; 30(4):188-193. PubMed ID: 30956258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Treatment for Hyperlipidemia with Decreased Total Mortality in Japanese Individuals: the Yamagata (Takahata) Study.
    Daimon M; Oizumi T; Kameda W; Matsui J; Murakami H; Ueno Y; Kubota I; Yamashita H; Kayama T; Kato T
    J Atheroscler Thromb; 2015; 22(10):1030-9. PubMed ID: 26016512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of calculated plasma volume status on all-cause and cardiovascular mortality: 4-year nationwide community-based prospective cohort study.
    Otaki Y; Watanabe T; Konta T; Watanabe M; Asahi K; Yamagata K; Fujimoto S; Tsuruya K; Narita I; Kasahara M; Shibagaki Y; Iseki K; Moriyama T; Kondo M; Watanabe T
    PLoS One; 2020; 15(8):e0237601. PubMed ID: 32817643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study.
    Schjelderup P; Dahle DO; Holdaas H; Mjøen G; Nordby G; Abedini S; Jardine A; Fellström B; Svensson M
    Clin Transplant; 2013; 27(6):E636-43. PubMed ID: 23991916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality. A population-based study.
    Arbel Y; Weitzman D; Raz R; Steinvil A; Zeltser D; Berliner S; Chodick G; Shalev V
    Thromb Haemost; 2014 Feb; 111(2):300-7. PubMed ID: 24173039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia status, hemoglobin concentration, and mortality in nursing home older residents.
    Landi F; Russo A; Danese P; Liperoti R; Barillaro C; Bernabei R; Onder G
    J Am Med Dir Assoc; 2007 Jun; 8(5):322-7. PubMed ID: 17570312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study (Nord-Trøndelag Health Study).
    Lyngbakken MN; Skranes JB; de Lemos JA; Nygård S; Dalen H; Hveem K; Røsjø H; Omland T
    Circulation; 2016 Dec; 134(24):1962-1972. PubMed ID: 27815376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive assessment of the association between anemia, clinical covariates and outcomes in a population-wide heart failure registry.
    Jonsson A; Hallberg AC; Edner M; Lund LH; Dahlstrom U
    Int J Cardiol; 2016 May; 211():124-31. PubMed ID: 26999301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients.
    Arsov S; Trajceska L; van Oeveren W; Smit AJ; Dzekova P; Stegmayr B; Sikole A; Rakhorst G; Graaff R
    Artif Organs; 2013 Jul; 37(7):E114-22. PubMed ID: 23635017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.